Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The distal human intestine harbors trillions of microbes that allow us to extract calories from otherwise indigestible dietary polysaccharides. The products of polysaccharide fermentation include short-chain fatty acids that are ligands for Gpr41, a G protein-coupled receptor expressed by a subset of enteroendocrine cells in the gut epithelium. To examine the contribution of Gpr41 to energy balance, we compared Gpr41 −/− and Gpr41 +/+ mice that were either conventionally-raised with a complete gut microbiota or were reared germ-free and then cocolonized as young adults with two prominent members of the human distal gut microbial community: the saccharolytic bacterium, Bacteroides thetaiotaomicron and the methanogenic archaeon, Methanobrevibacter smithii . Both conventionally-raised and gnotobiotic Gpr41 −/− mice colonized with the model fermentative community are significantly leaner and weigh less than their WT (+/+) littermates, despite similar levels of chow consumption. These differences are not evident when germ-free WT and germ-free Gpr41 knockout animals are compared. Functional genomic, biochemical, and physiologic studies of germ-free and cocolonized Gpr41 −/− and +/+ littermates disclosed that Gpr41-deficiency is associated with reduced expression of PYY, an enteroendocrine cell-derived hormone that normally inhibits gut motility, increased intestinal transit rate, and reduced harvest of energy (short-chain fatty acids) from the diet. These results reveal that Gpr41 is a regulator of host energy balance through effects that are dependent upon the gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Rodent-based studies also suggest that SCFAs may influence gut motility [57], suppress appetite (through enhanced incretin [glucagon-like peptide-1, GLP-1] release) and enhance insulin sensitivity [58].”
From The Health Benefits of Dietary Fibre (2020) · cites this paper as [57]
In the citing paper
“indigestible carbohydrates in the diet are fermented by the intestinal microbiota to produce short-chain fatty acids, which regulate immune function54, 55, intestinal hormone production, and lipogenesis56.”
From Diet and the Intestinal Microbiome: Associations, Functions, and Implications for Health and Disease (2014) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 13×
“Our proteome has a very limited repertoire of glycoside hydrolases needed to digest complex dietary plant polysaccharides: the microbiota synthesizes a large arsenal of these enzymes (2), and allows us to process complex dietary carbohydrates to short-chain fatty acids (SCFAs), principally acetate, propionate, and but…”
BackgroundInfluentialSelf-citationDiversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913 · cited 1×
“In addition, colonization of adult GF mice, fed a standard polysacchariderich chow diet, with two organisms—Bacteroides thetaiotaomicron, a prominent saccharolytic bacterium in the normal distal human gut microbiota and an adept adaptive forager of polysaccharides (6), plus Methanobrevibacter smithii, a dominant metha…”
BackgroundThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 1×
“Adult germ-free (GF) mice are leaner than their age- and gender-matched conventionally raised (CONV-R) counterparts who have acquired a microbiota beginning at birth (1).”
BackgroundSelf-citationTurnbaugh, P. J., Bäckhed, F., Fulton, L., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.02.015 · Cited by 2,915 · cited 13×
“Our proteome has a very limited repertoire of glycoside hydrolases needed to digest complex dietary plant polysaccharides: the microbiota synthesizes a large arsenal of these enzymes (2), and allows us to process complex dietary carbohydrates to short-chain fatty acids (SCFAs), principally acetate, propionate, and but…”
BackgroundInfluentialSelf-citationMechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615 · cited 1×
“Locomotor activity and body temperature were assessed for 5 d using a telemetry device (minimitter PDT-4000; Mini Mitter) beginning 7 d after implantation (20).”
MethodSelf-citationBrown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409
Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis
Flint, H. J., Bayer, E. A., Rincon, M. T., Lamed, R., & White, B. A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1817 · Cited by 1,711 · cited 1×
“Our proteome has a very limited repertoire of glycoside hydrolases needed to digest complex dietary plant polysaccharides: the microbiota synthesizes a large arsenal of these enzymes (2), and allows us to process complex dietary carbohydrates to short-chain fatty acids (SCFAs), principally acetate, propionate, and but…”
BackgroundLe Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301403200 · Cited by 1,651
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120
Hirasawa, A., Tsumaya, K., Awaji, T., Katsuma, S., Adachi, T., Yamada, M., Sugimoto, Y., Miyazaki, S., & Tsujimoto, G. (2005) · Nature Medicine · doi:10.1038/nm1168 · Cited by 1,545
Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., et al. (2003) · Nature · doi:10.1038/nature01478 · Cited by 1,538
Cited by
Items 701–800 of 1,001
Does the Gut Microbiota Contribute to Obesity? Going beyond the Gut Feeling
Aguirre, M., & Venema, K. (2015) · Microorganisms · doi:10.3390/microorganisms3020213 · Cited by 60
“expression, a hormone that increases energy metabolism and inhibits the feeling of hunger, has also been found to be stimulated by GPCR41 activation [77].”
BackgroundAw, W., & Fukuda, S. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0456-2 · Cited by 55
Duffy, L. C., Raiten, D. J., Hubbard, V. S., & Starke-Reed, P. E. (2015) · Journal of Nutrition · doi:10.3945/jn.114.194936 · Cited by 56
“In addition to being energy sources, SCFAs control colonic gene expression and metabolic regulation by G-protein–coupled receptors (32).”
BackgroundRifaximin in non‐alcoholic steatohepatitis: An open‐label pilot study
Cobbold, J., Atkinson, S. R., Marchesi, J. R., Smith, A., Wai, S. N., Stove, J., Shojaee‐Moradie, F., Jackson, N., Umpleby, A. M., Fitzpatrick, J. A., et al. (2017) · Hepatology Research · doi:10.1111/hepr.12904 · Cited by 55
Yu, D., Zhu, W., & Hang, S. (2019) · Animals · doi:10.3390/ani9040180 · Cited by 54
Lee, M., Hsu, Y.-J., Chuang, H.-L., Hsieh, P.-S., Ho, H.-H., Chen, W.-L., Chiu, Y., & Huang, C. (2019) · Nutrients · doi:10.3390/nu11092003 · Cited by 63
The Interplay between Immune System and Microbiota in Diabetes
Moffa, S., Mezza, T., CEFALO, C. M. A., Cinti, F., Impronta, F., Sorice, G. P., Santoro, A., Giuseppe, G. D., Pontecorvi, A., & Giaccari, A. (2019) · Mediators of Inflammation · doi:10.1155/2019/9367404 · Cited by 55
“These results reveal that Gpr41 is a regulator of host energy balance through effects that are dependent upon the gut microbiota [34].”
BackgroundNishida, A., Miyamoto, J., Shimizu, H., & Kimura, I. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.03.167 · Cited by 55
Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
Gupta, H., Min, B.-H., Ganesan, R., Gebru, Y. A., Sharma, S. P., Park, E., Won, S., Jeong, J., Lee, S.-B., Cha, M., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10030550 · Cited by 56
Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD)
Guo, Q., Li, Y., Dai, X., Wang, B., Zhang, J., & Cao, H. (2023) · Nutrients · doi:10.3390/nu15173722 · Cited by 53
Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease
Park, J. S., Seo, J. H., & Youn, H.-S. (2013) · Pediatric Gastroenterology, Hepatology & Nutrition · doi:10.5223/pghn.2013.16.1.22 · Cited by 49
“[30], expression of peptide YY (PYY) was lower in both Gpr41-deficient germ-free and conventionalized mice than in Gpr41 intact mice.”
BackgroundNonalcoholic fatty liver disease: Diagnosis, pathogenesis, and management
Basaranoglu, M., & Ormeci, N. (2014) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2014.7675 · Cited by 48
“Germ-free (GF) C57BL/6J mice are microbe-free and resistant to diet-induced obesity (31-34).”
BackgroundAsthma and Obesity in Children
Sansone, F., Attanasi, M., Pillo, S. D., & Chiarelli, F. (2020) · Biomedicines · doi:10.3390/biomedicines8070231 · Cited by 58
Zhao, J., Wang, L., Cheng, S., Zhang, Y., Yang, M., Fang, R., Li, H., Man, C., & Jiang, Y. (2022) · Nutrients · doi:10.3390/nu14020377 · Cited by 56
“(a) The contents of GLP-1 and PYY in serum (determined by Elisa kits) and the mRNA expression of GPR41/43 in colon tissue (determined by RT-PCR); (b) the contents of TNF-α, IL-6 and IL-10 in serum (determined by ELISA kits).”
BackgroundInfluentialGut Microbiota Drives Metabolic Disease in Immunologically Altered Mice
Chassaing, B., Aitken, J. D., Gewirtz, A. T., & Vijay–Kumar, M. (2012) · Advances in immunology · doi:10.1016/b978-0-12-394300-2.00003-x · Cited by 53
“ability to store energy as fat and to respond to energy intake via release of gut hormones such as peptide YY (PYY) (Cani &Delzenne, 2009; Samuel et al., 2008) and incretin glucagon-like peptide (GLP)-1 (Barrera, Sandoval, D’Alessio, & Seeley, 2011; Cani, Hoste, Guiot, & Delzenne, 2007; Cani, Lecourt, et al.”
BackgroundMicrobial regulation of enteroendocrine cells
Arora, T., Vanslette, A. M., Hjorth, S. A., & Bäckhed, F. (2021) · Med · doi:10.1016/j.medj.2021.03.018 · Cited by 59
Cella, V., Bimonte, V. M., Sabato, C., Paoli, A., Baldari, C., Campanella, M., Lenzi, A., Ferretti, E., & Migliaccio, S. (2021) · Foods · doi:10.3390/foods10123075 · Cited by 70
Pseudopod-like basal cell processes in intestinal cholecystokinin cells
Chandra, R., Samsa, L. A., Vigna, S. R., & Liddle, R. A. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-0997-1 · Cited by 48
“In these mice, enhanced GFP expression is driven by the CCK promoter resulting in green fluorescence only in CCK cells (Samuel et al. 2008).”
BackgroundLi, G., Su, H., Zhou, Z., & Yao, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097342 · Cited by 48
“adipocytes [7] and the effect of gut microbiota on host adiposity and energy balance in mice [14], and that GPR43 mediated the”
BackgroundZhang, J., Zhao, Y., Ren, D., & Yang, X. (2019) · Food Research International · doi:10.1016/j.foodres.2019.108929 · Cited by 52
Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
Zhou, J., Tripathi, M., Sinha, R. A., Singh, B. K., & Yen, P. M. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2020.134 · Cited by 62
“Activation of GPCRs stimulates peptide YY (PYY) release, which slows gastric emptying and thus enhances nutrient absorption([95,96]).”
BackgroundRani, L., & Mondal, A. C. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.01.001 · Cited by 50
Microbiome‐immune‐metabolic axis in the epidemic of childhood obesity: Evidence and opportunities
Kincaid, H. J., Nagpal, R., & Yadav, H. (2019) · Obesity Reviews · doi:10.1111/obr.12963 · Cited by 52
“FFAR2/3 signaling stimulated by butyrate increases the production of glucagon‐like peptide 1 (GLP‐1) and peptide YY (PYY) which increase insulin secretion and affect energy intake/expenditure.(23,24) In addition, SCFA‐ stimulated FFAR2/3 signaling is also involved in the regulation of immune cell functions such as ant…”
BackgroundIntestinal microbiota and their metabolic contribution to type 2 diabetes and obesity
Cunningham, A., Stephens, J. W., & Harris, D. A. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00858-4 · Cited by 51
“This was first demonstrated using GPR41 deficient mice that display significantly lower leptin levels than corresponding wild-type mice [65].”
BackgroundCommunication between the gut microbiota and peripheral nervous system in health and chronic disease
Cook, T. M., & Mansuy‐Aubert, V. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2068365 · Cited by 49
“Conversely, other studies show that SCFAs increase dietary energy harvest and weight gain, leading to disrupted glucose homeostasis.(129,130) Finding the right dose and method of delivery may be necessary to establish SCFAs as a safe and effective dietary supplement.”
BackgroundDynamic Changes in the Gut Microbial Community and Function during Broiler Growth
Yang, M., Shi, L., Ge, Y., Leng, D., Zeng, B., Wang, T., Jie, H., & Li, D. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01005-22 · Cited by 52
Microbial sensing in the intestine
Wan, T., Wang, Y., He, K., & Zhu, S. (2023) · Protein & Cell · doi:10.1093/procel/pwad028 · Cited by 51
Hamed, S., Mohan, A., Krishnan, S. N., Wang, A., Drikic, M., Prince, N. L., Lewis, I. A., Shearer, J., Keita, Å. V., Söderholm, J. D., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2281011 · Cited by 52
“Little is known of FFAR3 biology in the gut 60 ; thus, given the recognized benefits of SCFAs to host physiology, 61 greater research on the FFARs/GPRs is warranted.”
BackgroundDelzenne, N. M., & Cani, P. D. (2009) · International Dairy Journal · doi:10.1016/j.idairyj.2009.11.006 · Cited by 55
Kaji, I., Akiba, Y., Konno, K., Watanabe, M., Kimura, S., Iwanaga, T., Kuri, A., Iwamoto, K., Kuwahara, A., & Kaunitz, J. D. (2016) · The Journal of Physiology · doi:10.1113/jp271441 · Cited by 49
Fernández-Navarro, T., Salazar, N., Gutiérrez‐Díaz, I., Reyes‐Gavilán, C. G. D. L., Gueimonde, M., & González, S. (2017) · Nutrients · doi:10.3390/nu9060551 · Cited by 51
“In this regard, it is known that the major SCFA synthesized by the colonic microbiota (acetic, propionic, and butyric) play a key role in regulating host energy balance in extra-intestinal organs, such as the liver and adipose tissue [15,16].”
BackgroundResultAn overview of energy and metabolic regulation
Wen, S., Wang, C., Gong, M., & Zhou, L. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9371-4 · Cited by 55
Gut microbiota: An intermediary between metabolic syndrome and cognitive deficits in schizophrenia
Zeng, C., Yang, P., Cao, T., Gu, Y., Li, N., Zhang, B., Xu, P., Liu, Y., Luo, Z., & Cai, H. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110097 · Cited by 55
Microbiome-encoded bile acid metabolism modulates colonic transit times
Li, N., Koester, S. T., Lachance, D. M., Dutta, M., Cui, J. Y., & Dey, N. (2021) · iScience · doi:10.1016/j.isci.2021.102508 · Cited by 51
Arora, T., Rudenko, O., Egerod, K. L., Husted, A. S., Kovatcheva‐Datchary, P., Akrami, R., Kristensen, M., Schwartz, T. W., & Bäckhed, F. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00391.2018 · Cited by 46
“However, since hormone-producing enteroendocrine cells express GPR41 (41) but not GPR81 (30), it is tempting to speculate that the transcriptional changes we observed are mediated via GPR41 and can contribute to the beneficial effects of fiber supplementation (9), such as reduced adiposity (52).”
BackgroundReid, D. T., Eller, L. K., Nettleton, J. E., & Reimer, R. A. (2015) · Zeitschrift für Ernährungswissenschaft · doi:10.1007/s00394-015-1047-2 · Cited by 46
“Bacterial fermentation of prebiotic fibre in the large bowel produces SCFA, which may influence GLP-1 and PYY secretion [43, 44].”
BackgroundMach, N., Ramayo‐Caldas, Y., Clark, A. P., Moroldo, M., Robert, C., Barrey, É., Martí, J. M. L., & Moyec, L. L. (2017) · BMC Genomics · doi:10.1186/s12864-017-3571-3 · Cited by 48
“(XLSX 159 kb) Abbreviations 1H NMR: Proton nuclear magnetic resonance; ACAB: Acetyl-CoA carboxylase; ACSS: Acyl-CoA synthetase short-chain family; AHCTF1: AT-hook containing transcription factor 1; AMPK: Activated protein kinase; ANOVA: Analysis of variance; ATP5: ATP Synthase, H+ Transporting, Mitochondrial F1 Comple…”
InfluentialFree fatty acid receptor 3 activation suppresses neurogenic motility in rat proximal colon
Kaji, I., Akiba, Y., Furuyama, T., Adelson, D. W., Iwamoto, K., Watanabe, M., Kuwahara, A., & Kaunitz, J. D. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13157 · Cited by 51
Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases
Schiattarella, G. G., Sannino, A., Esposito, G., & Perrino, C. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.08.003 · Cited by 48
Influence of the microbiota and probiotics in obesity
Fontané, L., Benaiges, D., Goday, A., Llauradó, G., & Pedro‐Botet, J. (2018) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2018.10.002 · Cited by 54
Modasia, A., Parker, A., Jones, E., Stentz, R., Brion, A., Goldson, A., Defernez, M., Wileman, T., Ashley Blackshaw, L., & Carding, S. R. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.575595 · Cited by 46
“Using two bacteria to conventionalize germfree mice a role for the GPR41 receptor in regulating host energy balance has been identified in a process involving bacterial modulation of PYY expression (Samuel et al., 2008).”
BackgroundManco, M. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00109 · Cited by 46
“For instance, the interaction between SCFAs produced by the gut bacteria, and Gpr41 increases circulating levels of PYY, a potent orexigenic agent (Samuel et al., 2008).”
BackgroundMathur, R., Chua, K. S., Mamelak, M., Morales, W., Barlow, G. M., Thomas, R., Stefanovski, D., Weitsman, S. R., Marsh, Z. A., Bergman, R. N., et al. (2016) · Obesity · doi:10.1002/oby.21385 · Cited by 48
“Various mechanisms have been proposed to explain how intestinal microbes affect host metabolism and weight gain (30-33) (reviewed in (24)).”
BackgroundShao, T., He, Z., Xie, Z., Li, H., Wang, M.-J., & Wen, C. (2016) · Metabolomics · doi:10.1007/s11306-016-1000-2 · Cited by 49
“Gut microbes exert strong effects on maturation and development of the host’s immune system (Round and Mazmanian 2009), maintenance of host energy (Samuel et al. 2008) and metabolic homeostasis (Cani and Delzenne 2007).”
BackgroundMethodPossible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS)
El‐Salhy, M., Hatlebakk, J. G., & Hausken, T. (2019) · Neuropeptides · doi:10.1016/j.npep.2019.101973 · Cited by 52
“SCFA has been found to increase the secretion and upregulate the gene expression of PYY (Karaki et al., 2006; Samuel et al., 2008; Zhou et al., 2008).”
Difference of gut microbiota composition based on the body condition scores in dogs
Chun, J. L., Ji, S. Y., Lee, S. D., Lee, Y. K., Kim, B., & Kim, K. H. (2020) · Journal of Animal Science and Technology · doi:10.5187/jast.2020.62.2.239 · Cited by 56
“Microbiota produces SCFAs as the end products of fermentation after digesting the non - digestible fibers [9,10] and is used as an energy source of the host [11].”
BackgroundDagbasi, A., Lett, A. M., Murphy, K., & Frost, G. (2020) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120006941 · Cited by 44
“In addition, studies using FFAR2/3 knock out animal models reported inconsistent outcomes on body weight((115,134)).”
Luo, Q.-J., Sun, M.-X., Guo, Y., Tan, S.-W., Wu, X., Abassa, K.-K., Lin, L., Liu, H., Jiang, J., & Wei, X.-Q. (2020) · Gastroenterology report · doi:10.1093/gastro/goaa085 · Cited by 49
Zhang, Y., Li, X., Huang, G., Wang, H., Chen, H., Su, Y., Yu, K., & Zhu, W. (2022) · Animal nutrition · doi:10.1016/j.aninu.2022.06.003 · Cited by 51
“For example, mice lacking FFAR2/FFAR3 have reduced SCFA-triggered PYY and GLP-1 secretion (Samuel et al., 2008; Tolhurst et al., 2012).”
BackgroundBahar Halpern, K., Veprik, A., Rubins, N., Naaman, O., & Walker, M. D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.358887 · Cited by 44
Yeom, Y., Kim, B. S., Kim, S.-J., & Kim, Y. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1456-7 · Cited by 46
“Butyrate is a key energy source for epithelial cells of the colon and it suppresses pro-inflammatory cytokines in the gut [45].”
BackgroundInfluencia de la microbiota y de los probióticos en la obesidad
Fontané, L., Benaiges, D., Goday, A., Llauradó, G., & Pedro‐Botet, J. (2018) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2018.03.004 · Cited by 70
Yi, X., Ren, M., Yang, J., Cai, C., Cheng, W., Zhou, X., Lu, D., & Ji, F. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1003755 · Cited by 48
“Decreased levels of ghrelin and increased levels of GLP-1 and PYY reduce hunger and increase satiation and satiety independently of weight loss for up to 10 years (Dar et al., 2012; Yousseif et al., 2014).”
BackgroundInfluentialRewiring the Brain Through the Gut: Insights into Microbiota–Nervous System Interactions
Săvulescu-Fiedler, I., Benea, S. N., Căruntu, C., Nancoff, A.-S., Homentcovschi, C., & Bucurica, S. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47070489 · Cited by 52
“The microbiota either release microbial components (like LPS), for which there are TLR receptors on the EECs, or release metabolites (like SCFAs), for which there are receptors on the EECs [47,170].”
Gut microbiota and the development of obesity.
Moreira, A. P. B., Teixeira, T. F. S., Pelúzio, M. D. C. G., & Alfenas, R. D. C. G. (2012) · PubMed · doi:10.3305/nh.2012.27.5.5887 · Cited by 61
Restoring the gut microbiome for the treatment of inflammatory bowel diseases
Allegretti, J. R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i13.3468 · Cited by 43
Shi, G., Sun, C., Gu, W., Yang, M., Zhang, X., Zhai, N., Lü, Y., Zhang, Z., Shou, P., Zhang, Z., et al. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0065 · Cited by 44
“Yanagisawa’s group first demonstrated that FFAR3-stimulated leptin secretion in adipocytes and regulated gut hormones and motility (Xiong et al. 2004, Samuel et al. 2008).”
Comparison of the microbiome, metabolome, and lipidome of obese and non-obese horses
Coleman, M. C., Whitfield-Cargile, C., Madrigal, R. G., & Cohen, N. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215918 · Cited by 46
Microbiome and substances of abuse
Salavrakos, M., Leclercq, S., de Timary, P., & Dom, G. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110113 · Cited by 48
Genetics of irritable bowel syndrome: shifting gear via biobank-scale studies
Camilleri, M., Zhernakova, A., Bozzarelli, I., & D’Amato, M. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00662-2 · Cited by 55
Peripheral neural targets in obesity
Page, A. J., Symonds, E., Peiris, M., Blackshaw, L. A., & Young, R. L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01951.x · Cited by 43
G protein–coupled receptor modulation with pepducins: moving closer to the clinic
Dimond, P. F., Carlson, K. E., Bouvier, M., Gerard, C. J., Xu, L., Covic, L., Agarwal, A., Ernst, O. P., Janz, J. M., Schwartz, T. W., et al. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06039.x · Cited by 43
Axon‐Like Basal Processes in Enteroendocrine Cells: Characteristics and Potential Targets
Bohórquez, D. V., & Liddle, R. A. (2011) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00299.x · Cited by 43
Stammler, D., Eigenbrod, T., Menz, S., Frick, J.-S., Sweet, M. J., Shakespear, M. R., Jantsch, J., Siegert, I., Wölfle, S. J., Langer, J. D., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501195 · Cited by 46
“It is the primary energy source for intestinal epithelial cells and, further, it is recognized by important receptors of the GPCR family (GPR41 and GPR43) (49).”
Di, S., Wang, Y., Han, L., Bao, Q. D., Gao, Z., Wang, Q., Yang, Y., Zhao, L., & Tong, X. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/2958920 · Cited by 46
“PYY produced by GPR41 is an enteroendocrine cell-derived hormone such as the incretins GLP-1 and glucose-dependent insulinotropic polypeptide, which normally inhibits gut motility and thereby absorbs more energy from feces, decreases the intestinal transit rate, and increases the harvest of energy from the diet [56].”
BackgroundEffects of dietary fibers and prebiotics in adiposity regulation via modulation of gut microbiota
Rivera‐Piza, A., & Lee, S. (2020) · Applied Biological Chemistry · doi:10.1186/s13765-019-0482-9 · Cited by 49
A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression
Iruzubieta, P., Medina, J. M., Fernández-López, R., Crespo, J., & de la Cruz, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051369 · Cited by 46
The emerging role of gut microbiota in cardiovascular diseases
Kumar, D., Mukherjee, S. S., Chakraborty, R., Roy, R. R., Pande, A., Patra, S., & Dey, S. (2021) · Indian Heart Journal · doi:10.1016/j.ihj.2021.04.008 · Cited by 43
Lu, Y., Liu, H., Yang, K., Mao, Y., Meng, L., Yang, L., Ouyang, G., & Liu, W. (2022) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2100182 · Cited by 47
Microbiota and epigenetics: promising therapeutic approaches?
El-Sayed, A., Aleya, L., & Kamel, M. S. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-15623-6 · Cited by 47
“Besides being a direct source of energy, SCFAs are also signaling molecules that modulate gene expression patterns to decrease gut transit time and promote obesity (Samuel et al. 2008; Turnbaugh et al. 2006).”
BackgroundEnteroendocrine cells: the gatekeepers of microbiome-gut-brain communication
Grundeken, E., & Aidy, S. E. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00810-x · Cited by 55
Host Energy Regulation via SCFAs Receptors, as Dietary Nutrition Sensors, by Gut Microbiota
Kimura, I. (2014) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.14-00169 · Cited by 41
Gut Microbiota: FFAR Reaching Effects on Islets
Priyadarshini, M., Navarro, G., & Layden, B. T. (2018) · Endocrinology · doi:10.1210/en.2018-00296 · Cited by 41
Microbiota in cerebrovascular disease: A key player and future therapeutic target
Tonomura, S., Ihara, M., & Friedland, R. P. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20918031 · Cited by 43
“On the other hand, propionate causes peptide YY production through GPR41, which inhibits intestinal motility and increases the absorption rate of nutrients through the intestinal epithelium.(51) The advance of metabolomic analyses enabled discovery of the molecular mechanisms between bacteria-derived metabolites of am…”
BackgroundBacteriophage-mediated modulation of microbiota for diseases treatment
Zhang, Y., Li, C., & Zhang, X. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113856 · Cited by 46
Tissue expression of angiopoietin-like protein 4 in cattle1
Mamedova, L. K., Robbins, K., Johnson, B. J., & Bradford, B. J. (2009) · Journal of Animal Science · doi:10.2527/jas.2009-2258 · Cited by 51
Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk
Koopen, A. M., Groen, A. K., & Nieuwdorp, M. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000357 · Cited by 40
Wei, H., Li, X., Tang, L., Yao, H., Ren, Z., Wang, C., Mu, C., Shi, C., & Wang, H. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.126891 · Cited by 44
Ticinesi, A., Mancabelli, L., Carnevali, L., Nouvenne, A., Meschi, T., Rio, D. D., Ventura, M., Sgoifo, A., & Angelino, D. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215493 · Cited by 44
Zhang, H., Cao, P., Agellon, L. B., & Zhai, C. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509991036 · Cited by 46
“Epididymal fat pad mass was used as an index of body fat mass((12,13)).”
MethodDruart, C., Neyrinck, A. M., Dewulf, E. M., Backer, F. C. D., Possemiers, S., de Wiele, T. V., Moens, F., Vuyst, L. D., Cani, P. D., Larondelle, Y., et al. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513000123 · Cited by 41
“For example, metabolites such as SCFA – mainly produced during the fermentation of non-digestible carbohydrates by saccharolytic bacteria – are able to be used both as metabolic substrates and regulators in host tissues((30,31)).”
BackgroundReshaping the Gut Microbiota at an Early Age: Functional Impact on Obesity Risk?
Luoto, R., Collado, M. C., Salminen, S., & Isolauri, E. (2013) · Annals of Nutrition and Metabolism · doi:10.1159/000354896 · Cited by 49
Key Questions for Translation of FFA Receptors: From Pharmacology to Medicines
Suckow, A. T., & Briscoe, C. P. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_45 · Cited by 40
Brahma, S., Martínez, I., Walter, J., Clarke, J., Gonzalez, T., Menon, R. S., & Rose, D. J. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2016.12.042 · Cited by 47
Onyszkiewicz, M., Jaworska, K., & Ufnal, M. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370219900898 · Cited by 39
Evidence for the Contribution of Gut Microbiota to Age-Related Anabolic Resistance
Watson, M. D., Cross, B. L., & Grosicki, G. J. (2021) · Nutrients · doi:10.3390/nu13020706 · Cited by 39
A role for the gut microbiota in energy harvesting?
Tremaroli, V., Kovatcheva-Datchary, P., & Bäckhed, F. (2010) · Gut · doi:10.1136/gut.2010.223594 · Cited by 38
“To this end, it is worthwhile considering that the metabolic activities of gut microbes, which result in the production of SCFA and other metabolites, not only affect the amount of energy that can be extracted from food but also the host’s ability to store energy and to respond to energy intake via the release of gut…”
BackgroundSelf-citationRew, L., Harris, M. D., & Goldie, J. H. (2022) · Gastroenterology and hepatology from bed to bench. · doi:10.22037/ghfbb.v15i4.2600 · Cited by 72
Kaufmann, B. K., Seyfried, N., Hartmann, D., & Hartmann, P. (2023) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00017.2023 · Cited by 44
Evolving paradigms in the nutritional support of critically ill surgical patients
Rosenthal, M. D., Vanzant, E. L., Martindale, R. G., & Moore, F. A. (2015) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2015.02.003 · Cited by 37
Posovszky, C., & Wabitsch, M. (2014) · Hormone Research in Paediatrics · doi:10.1159/000368898 · Cited by 47
Hartstra, A. V., Nieuwdorp, M., & Herrema, H. (2016) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2016.08.009 · Cited by 41
Vascular Cognitive Impairment and the Gut Microbiota
Li, S., Shao, Y., Li, K., HuangFu, C., Wang, W., Liu, Z., Cai, Z., & Zhao, B. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-171103 · Cited by 37
“Similarly, Samueletal.alsoreportedthatmicedeficientin FFAR3(Gpr41-/-)didnotdevelopincreasedadi-posity[143].”
Han, R., Ma, J., & Li, H. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0645-9 · Cited by 40
Gual‐Grau, A., Guirro, M., Mayneris‐Perxachs, J., Arola, L., & Boqué, N. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.06.005 · Cited by 43
Doroftei, B., Ilie, O., Cojocariu, R.-O., Ciobica, A. S., Maftei, R., Grab, D., Anton, E., McKenna, J., Dhunna, N., & Simionescu, G. (2020) · Molecules · doi:10.3390/molecules25153323 · Cited by 41
Kushwaha, V., Rai, P., Varshney, S., Gupta, S., Khandelwal, N., Kumar, D., & Gaikwad, A. N. (2022) · Food Chemistry Molecular Sciences · doi:10.1016/j.fochms.2022.100079 · Cited by 49
“These metabolites act as a signaling molecule, and their receptors are present in metabolic tissues (Samuel et al., 2008; Lu, Zhao, Meng, & Zhang, 2019).”
BackgroundResistant starch as a novel dietary strategy to maintain kidney health in diabetes mellitus
Koh, G. Y., & Rowling, M. J. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux006 · Cited by 39
Hesampour, F., Bernstein, C. N., & Ghia, J. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad211 · Cited by 39
Al‐Dwairi, A., Brown, A. R., Pabona, J. M. P., Van, T. H., Hamdan, H., Mercado, C. P., Quick, C. M., Wight, P. A., Simmen, R. C. M., & Simmen, F. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113058 · Cited by 39
“Fat storage in adipose and liver tissue involves many transporters and enzymes as well as cross-talk between tissues via the circulation, and can involve intestinal host-microbe interactions that modify the response to nutrients of key genes involved in lipid metabolism [8,30,51].”
Background
Metadata
- Authors
- Samuel, B. S., Shaito, A., Motoike, T., Rey, F. E., Backhed, F., Manchester, J. K., Hammer, R. E., Williams, S. C., Crowley, J., Yanagisawa, M., & Gordon, J. I.
- Affiliations
- Washington University in St. Louis (US)
- The University of Texas Southwestern Medical Center (US)
- Japan Science and Technology Agency (JP)
- *Center for Genome Sciences and
- Howard Hughes Medical Institute (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-10-28
- Volume
- 105
- Issue
- 43
- Pages
- 16767-16772
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2569967
- OpenAlex
- W2142336938
- Cited by
- 1,564
- References
- 23
- Citations by year
- 2026: 51 · 2025: 83 · 2024: 71 · 2023: 93 · 2022: 110 · 2021: 137 · 2020: 127 · 2019: 110 · 2018: 107 · 2017: 104 · 2016: 110 · 2015: 87 · 2014: 88 · 2013: 80 · 2012: 70
- FWCI
- 18.36
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute of Diabetes and Digestive and Kidney Diseases (R37DK030292, DK-30292, DK 70977, R01DK070977, P30DK056341, R01DK030292)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- GPR41, gut microbiota, adiposity, short-chain fatty acids, energy balance, Bacteroides thetaiotaomicron, Methanobrevibacter smithii, peptide YY, enteroendocrine cells, intestinal transit, gnotobiotic mice, germ-free mice, polysaccharide fermentation, host-microbe interactions
- MeSH terms
- Animals, Bacteroides, Energy Metabolism, Germ-Free Life, Humans, Symbiosis, Mice, Knockout, Peptide YY, Methanobrevibacter, Gastrointestinal Tract, Receptors, G-Protein-Coupled, Adiposity, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.